Skip to content
InsideEdge
Investors / filer profile

Track record

What happened ~6 months after each disclosed buy

+124.3%avg per buy, ~6 months on+1.8%S&P 500 avg, same spans
STTK · 2025-08-25 · +302.4% (S&P +6.3%)ACET · 2025-10-08 · -53.7% (S&P -2.7%)
2025-08-252025-10-08
Each dot: one completed buy’s ~6-month outcome, equal weight per buy · dashed: S&P 500 over the same spans · hover a dot for detail
1 of 2
buys higher ~6mo later
+302.4%
median outcome
+6.3%
S&P 500 median, same spans

1 buy still inside the ~6-month window — not scored yet.

Disclosed positions

Estimated from their latest filings — positions may have changed since

$621.44M
combined est. value
ELVN
Enliven Therapeutics, Inc.
$333.79M
6,555,102 sh
SION
Sionna Therapeutics, Inc.
$120.04M
2,671,721 sh
CRVS
Corvus Pharmaceuticals, Inc.
$109.12M
7,165,006 sh
ACET
Adicet Bio, Inc.
$38.62M
4,490,254 sh
QTTB
Q32 Bio Inc.
$8.51M
625,000 sh
STTK
Shattuck Labs, Inc.
$7.57M
1,051,021 sh
IMA
ImageneBio, Inc.
$1.75M
287,885 sh
PASG
Passage BIO, Inc.
$1.52M
303,317 sh
KROS
Keros Therapeutics, Inc.
$524.9K
45,057 sh
PMVP
PMV Pharmaceuticals, Inc.
—
4,975,291 sh

Activity

Open-market buy & sell volume

BuySell
0$26.5M$53.1M2025 · bought $10.5M · sold $13.9M20252026 · bought $15.0M · sold $53.1M2026
Total +$25.47M bought · −$66.96M sold

All filings on record

Every Form 4 transaction we track for this filer

ELVNSell
2026-06-22 · Enliven Therapeutics, Inc.
$2.10M
—
ELVNSell
2026-06-22 · Enliven Therapeutics, Inc.
$35.72M
—
ELVNSell
2026-06-22 · Enliven Therapeutics, Inc.
$66.5K
—
ELVNSell
2026-06-22 · Enliven Therapeutics, Inc.
$1.13M
—
ELVNSell
2026-06-15 · Enliven Therapeutics, Inc.
$12.26M
—
ELVNSell
2026-06-15 · Enliven Therapeutics, Inc.
$409.1K
—
QTTBBuy
2026-05-28 · Q32 Bio Inc.
$5.00M
in progress
QTTBBuy
2026-05-28 · Q32 Bio Inc.
$10.00M
in progress
SIONSell
2026-05-27 · Sionna Therapeutics, Inc.
$4.5K
—
SIONSell
2026-02-03 · Sionna Therapeutics, Inc.
$1.30M
—
SIONSell
2026-02-02 · Sionna Therapeutics, Inc.
$84.2K
—
SIONSell
2025-12-24 · Sionna Therapeutics, Inc.
$1.49M
—
SIONSell
2025-12-19 · Sionna Therapeutics, Inc.
$38.9K
—
SIONSell
2025-12-18 · Sionna Therapeutics, Inc.
$4.4K
—
SIONSell
2025-12-17 · Sionna Therapeutics, Inc.
$40.0K
—
SIONSell
2025-11-26 · Sionna Therapeutics, Inc.
$71.2K
—
SIONSell
2025-11-25 · Sionna Therapeutics, Inc.
$530.3K
—
SIONSell
2025-11-24 · Sionna Therapeutics, Inc.
$4.21M
—
KROSReturn
2025-11-21 · Keros Therapeutics, Inc.
$1.32M
—
KROSReturn
2025-11-21 · Keros Therapeutics, Inc.
$2.49M
—
PMVPSell
2025-10-23 · PMV Pharmaceuticals, Inc.
$1.52M
—
ACETBuy
2025-10-08 · Adicet Bio, Inc.
$3.50M
-53.7%
ACETBuy
2025-10-08 · Adicet Bio, Inc.
$1.50M
-53.7%
PMVPSell
2025-09-10 · PMV Pharmaceuticals, Inc.
$900.0K
—
STTKBuy
2025-08-25 · Shattuck Labs, Inc.
$912.0K
+302.4%

Outcomes measure each disclosed buy against the closing price ~6 months (120 trading days) later, with the S&P 500 over the same span for context. Pre-scheduled 10b5-1 plan trades are excluded from the record. Positions are estimated from the latest reported post-transaction holdings, split-adjusted, at the latest close. Built from SEC Form 4 filings and market prices — past outcomes, not predictions or advice.